Replies to post #20773 on Biotech Values

[Praveen]

TEVA/Dew


I should have said significant revenues.
Sorry my mistake.

MNTA filing a biogeneric for copaxone is not official yet. But the next possible complex near term mixtures are copaxone, premarin and prevnar according to B Of America.

Dr.P